Welcome to our dedicated page for Hercules Capital SEC filings (Ticker: HCXY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hercules Capital, Inc. 6.25% Notes due 2033 (NYSE: HCXY) SEC filings page aggregates regulatory documents that reference these exchange-listed notes and their issuer, Hercules Capital, Inc. HCXY is identified in Hercules Capital’s Form 8-K as 6.25% Notes due 2033 registered under Section 12(b) of the Securities Exchange Act of 1934 and listed on the New York Stock Exchange. Filings that mention HCXY typically appear alongside disclosures about the company’s common stock (HTGC).
Through this page, users can access current reports on Form 8-K where Hercules Capital furnishes quarterly earnings press releases and announces board-approved cash distributions on its common stock. These filings confirm the continued registration and listing of HCXY and provide context on the issuer’s financial results, leverage levels, liquidity and distribution policy, all of which are relevant to assessing the credit profile behind the 6.25% Notes due 2033.
In addition to 8-Ks, investors may review other SEC filings for Hercules Capital, such as annual and quarterly reports when available, to understand the company’s business as a specialty finance provider of senior secured venture growth loans and its use of unsecured debt, including HCXY, within a diversified funding mix. Rating agency commentary cited by Hercules Capital notes that a high proportion of unsecured debt to total debt outstanding supports protection for noteholders, making those disclosures particularly pertinent for HCXY analysis.
Stock Titan enhances this filings page with AI-powered summaries that explain the key points of lengthy SEC documents in plain language. Users can quickly identify how a filing references the 6.25% Notes due 2033, what it reveals about Hercules Capital’s capital structure and operating performance, and how new information may affect perceptions of the issuer’s ability to service HCXY over the life of the notes.
Hercules Capital, Inc. director Thomas J. Fallon reported an indirect open-market purchase of 10,000 shares of common stock at $14.98 per share on February 24, 2026. The shares are held by the Fallon Family Revocable Trust.
After this transaction, the trust holds a total of 130,369 common shares, and Fallon also reports 5,779 common shares held directly. The filing highlights increased indirect ownership through the family trust structure.
Hercules Capital, Inc. director Gayle A. Crowell reported an open-market purchase of common stock. On February 23, 2026, Crowell bought 6,600 shares at a price of $15.20 per share. After this transaction, Crowell directly owned 87,458 shares of Hercules Capital common stock. The reported ownership total includes shares previously acquired through the company’s dividend reinvestment plan.
Hercules Capital, Inc. Chief Executive Officer Scott Bluestein bought 30,000 shares of common stock in an open-market purchase. The shares were acquired at an average price of $15.08 each, with individual trade prices ranging from $15.04 to $15.10. Following this transaction, Bluestein directly owns 2,509,379 shares of Hercules Capital common stock.
Hercules Capital director Nikos Theodosopoulos bought 6,165 shares of common stock in an open-market purchase. The transaction took place on February 17, 2026, at an average price of $15.93 per share. Following this purchase, his directly owned stake increased to 18,923 shares.
Hercules Capital, Inc. director Thomas J. Fallon reported an indirect open-market purchase of 20,000 shares of Common Stock on February 17, 2026, at an average price of $15.88 per share. A footnote explains the price reflects purchases between $15.81 and $15.92.
The 20,000 shares are held by the Fallon Family Revocable Trust, bringing its indirect holdings to 120,369 shares. Separately, Fallon directly holds 5,779 shares, which reflects his personal stake outside the trust.
Hercules Capital, Inc. reported record full-year 2025 results, with total investment income of $532.5 million, up 7.9% year-over-year, and net investment income of $341.7 million, or $1.91 per share, up 4.9%. Total gross debt and equity commitments reached $3.92 billion and gross fundings $2.28 billion.
In Q4 2025, total investment income was $137.4 million and net investment income was $87.0 million, or $0.48 per share, providing 120% coverage of the base cash distribution. Net asset value per share rose to $12.13 on 182.7 million shares.
The Board declared a fourth quarter 2025 total cash distribution of $0.47 per share, including a $0.40 base and $0.07 supplemental distribution, payable on March 4, 2026 to holders of record on February 25, 2026. A new supplemental cash distribution of $0.28 per share will be paid in four equal quarterly installments beginning with this quarter.
Hercules ended Q4 2025 with $525.5 million of available liquidity and a debt investment portfolio at fair value of $4.28 billion, 89.3% in first-lien senior secured loans and 97.9% floating rate. Loans on non-accrual fell to one position, representing 0.2% of the portfolio at cost. Subsequent to year-end, the company issued $300.0 million of 5.350% unsecured notes due 2029.
HCXY’s filing outlines a large, highly diversified investment portfolio centered on senior secured debt, plus related equity and warrant positions. The portfolio spans application software, drug discovery and development, healthcare services, consumer and business services, sustainable technology, space technology, semiconductors and more.
Most debt investments are floating-rate loans tied to 1- or 3‑month SOFR, Prime, or SONIA with substantial credit spreads, floor rates, and frequent payment‑in‑kind (PIK) and exit fee features, and maturities generally running from 2025 into the early 2030s. HCXY also holds numerous preferred and common equity stakes, as well as warrants, in many of the same portfolio companies, and participates in investment funds and foreign currency contracts.
The text also highlights structural risks, including security interests on assets securing senior securities, potential volatility if preferred stock or convertible debt is issued, lack of an active trading market for certain notes, SBIC regulatory oversight of subsidiaries, and the possibility that capital market disruptions or tariff changes could negatively affect portfolio companies.
Hercules Capital, Inc. has issued $300,000,000 in aggregate principal amount of its 5.350% Notes due 2029 under a Tenth Supplemental Indenture with U.S. Bank Trust Company, National Association. These unsecured notes pay 5.350% interest semiannually and mature on February 10, 2029, unless earlier redeemed.
The notes rank senior to expressly subordinated debt, equal with other unsubordinated liabilities, and are effectively and structurally subordinated to secured and subsidiary indebtedness. Hercules completed the transaction on February 10, 2026 and expects to use the net proceeds to fund investments, repay outstanding secured indebtedness and for other general corporate purposes.
Hercules Capital, Inc. is offering $300,000,000 aggregate principal amount of 5.350% unsecured notes due February 10, 2029. The notes pay cash interest semi-annually on February 10 and August 10, starting August 10, 2026, and were priced at 99.272% of par, implying proceeds slightly below face value.
The notes rank equally with Hercules Capital’s other unsecured unsubordinated debt, but are effectively subordinated to secured borrowings and structurally subordinated to debt at subsidiaries. Hercules may redeem the notes early, and holders can require repurchase at 100% of principal plus accrued interest following a Change of Control Repurchase Event.
Net proceeds of about $294 million are intended to fund new investments consistent with the company’s business development company strategy, repay amounts outstanding under the SMBC and MUFG bank facilities, and support other general corporate purposes, preserving balance-sheet flexibility while expanding its specialty finance lending capacity.
Hercules Capital, Inc., an internally managed business development company focused on senior secured lending to venture-backed technology and life sciences firms, is offering a new series of unsecured notes. The notes pay semi-annual cash interest and mature in 20__, with optional redemption by the company.
The notes rank equally with Hercules Capital’s other unsecured unsubordinated debt and are effectively subordinated to secured borrowings and structurally subordinated to liabilities at its subsidiaries. Holders can require repurchase at 100% of principal plus accrued interest after a Change of Control Repurchase Event.
Net proceeds are expected to fund new investments, repay borrowings under the SMBC and MUFG Bank credit facilities, and support general corporate purposes. The filing also details significant existing debt, asset coverage requirements as a BDC, and extensive risk factors around leverage, limited covenants, interest-rate sensitivity, liquidity of the notes, and unaudited preliminary financial estimates.